Monday, July 7, 2014
Paracetamol
Indication:
Fever,
headache, toothache, earache, bodyache, myalgia, dysmenorrhoea, neuralgia and
sprains. Pain of colic, back pain, chronic pain of cancer, inflammatory pain,
and post-vaccination pain and fever of children. Rheumatism and osteoarthritic
pain & stiffness of joints in fingers, hips, knees, wrists, elbows, feet, ankles
and top & bottom of the spine.
Dosage &
Administration:
Tablet: Adult 1-2 tablets every 4 to 6 hours up to a
maximum of 4 g (8 tablets) daily. Children (6-12 years) 1/2 to 1 tablet 3 to 4
times daily. XR
Tablet: 2 tablet every 6 to 8 hourly upto a maximum of 6 tablets daily. Syrup and Suspension: Children
Under 3 months: 10 mg/kg body weight (reduce to 5 mg/kg if
jaundiced) 3
to 4 times daily. 3 months to below 1 year : 1/2 to 1 teaspoonful 3 to 4 times
daily. 1-5 years: 1-2 teaspoonful 3 to 4 times daily. 6-12 years : 2-4
teaspoonful 3 to 4 times daily. Adults 4-8 teaspoonful 3 to 4 times daily. Paediatric Drop: Children
upto 3 months: 0.5 ml (40 mg) 4 to 11 months:
1.0 ml (80
mg). 1 to 2 years: 1.5 ml (120 mg) Dose can be repeated, every 4 hours.
Suppository: Suppository
should be administered rectaly. Children 3 months -
1 year :
60-120 mg 4 times daily. Children below 5 years : 125-250 mg, 4 times daily. Children
6-12 years : 250-500 mg, 4 times daily. Adults and children over 12 years : 0.5
- 1 mg, 4 times daily.
Contraindication
& Precaution:
Known sensitivity to paracetamol.
Side Effect:
Side Effects
are significantly mild, though haematological reactions
have been
reported. Pancreatitis, skin rashes, and other allergic reactions occur
alcoholics or
in patients taking other antiepilectic medications.
Precaution:
Should be given cautiously in the
following cases: In patients with hepatic or renal failure, in patients taking other
hepatotoxic medication. Prolonged
use of the
drug without consulting a physician should be avoided.
Preparation:
Paracetamol
500 mg & Caffeine 65 mg.
Friday, June 6, 2014
Esomeprazole
Esomeprazole
Indication: Nexum is indicated for the treatment of - Gastroesophageal Reflux Disease (GERD), Healing of Erosive Esophagitis, Maintenance of healing of Erosive Esophagitis, Symptomatic Gastroesophageal Reflux Disease (GERD), Risk Reduction of NSAIDassociated gastric ulcer & H. pylori eradication (Triple therapy).
Dosage & Administration: Tablet and capsule: Recommended adult dosage schedule of Esomeprazole is –
Indications
|
Dose
|
Frequency
| |
Gastroesophageal Reflux Disease (GERD)
| |||
Healing of erosive esophagitis
|
20 mg or 40 mg
|
Once daily for 4 to 8 weeks*
| |
Maintenance of healing of
erosive esophagitis
|
20 mg
|
Once daily**
| |
Symptomatic GERD
|
20 mg
|
Once daily for 4 weeks ***
| |
Risk Reduction of NSAID associated
gastric ulcer
|
20 mg or 40 mg
|
Once daily for up to
6 months**
| |
H. pylori eradication (Triple therapy)
| |||
Esomeprazole
|
20 mg
|
Twice daily for 10 days
| |
Amoxicillin
|
1000 mg
|
Twice daily for 10 days
| |
Clarithromycin
|
500 mg
|
Twice daily for 10 days
|
Paediatric use (12 years and older)
Short term treatment of GERD: 20 mg or 40 mg once daily for up to 8 weeks.
• The majority of patients are healed within 4 to 8 weeks. For patients who do not heal
after 4-8 weeks, an additional 4-8 weeks treatment may be considered.
• Controlled studies did not extend beyond 6 months.
• If symptoms do not resolve completely after 4 weeks, an additional 4 weeks of treatment may be considered.
Injection
Duodenal ulcer, gastric ulcer, gastrointestinal lesions refractory to H2 blockers, Zollinger-Ellison syndrome
|
40 mg per day
intravenously
|
Reflux esophagitis
|
20-40 mg per day
intravenously
|
Direction for use of IV Injection
Esomeprazole lyophilized powder and 0.9% Sodium Chloride Injection is for intravenous administration only and must not be given by any other route. Esomeprazole injection 40 mg should be given as a slow intravenous injection. The solution for IV injection is obtained by adding 5 ml 0.9% Sodium Chloride Injection to the vial containing powder.
After reconstitution the injection should be given slowly over a period of at least 3 minutes. Use only freshly prepared solution. The reconstituted solution may be stored at room temperature (up to 30oc) for a maximum 12 hours. Half of the IV injection should be used when 20 mg to be administered.
Direction for use of IV Infusion
Esomeprazole IV 40 mg should be given as an intravenous infusion over a period of 10 to 30 minutes. Esomeprazole IV should be reconstituted with 5 ml of 0.9% Sodium Chloride Injection and further diluted (admixed) with 5% Dextrose Injection or 0.9% Sodium Chloride Injection or Lactated Ringer’s Injection to a final volume of 50 ml. The
reconstituted solution may be stored at room temperature (up to 30oc) for a maximum 12 hours prior to dilution. The admixed solution may be stored at room temperature (up to 30oc) and must be used within 12 hours when reconstituted with 0.9% Sodium Chloride Injection or Lactated Ringer’s Injection and within 6 hours when reconstituted with 5% Dextrose Injection.
Contraindication & Precaution:
Esomeprazole is contraindicated in those patients who have known hypersensitivity to any other components of the formulation. Exclude the possibility of malignancy when gastric ulcer is suspected and before treatment for dyspepsia.
Side-Effect:
Side Effects reported with Esomeprazole include headache, diarrhea and abdominal pain.
Use in Pregnancy & Lactation:
US FDA Pregnancy Category - ‘B’. This drug should be used during pregnancy only if clearly needed. Because Esomeprazole is likely to be excreted in human milk, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.
Preparation:
20 mg Tablet & Capsule, 40 mg Tablet & Capsule and 40 mg IV Injection.
Diphenhydramine
Diphenhydramine
Indication
For the treatment of following:
1) Seasonal, perennial & vasomotor rhinitis, 2) urticaria, angioneurotic edema, anaphylaxis, 3) pruritus, 4) preanesthetic medication, emesis, motion sickness, 5) miscellaneous including meniere’s
diseases and parkinsonism, 6) cough & cold. Sometimes it may use as a night time sleep aid and for the short-term management of insomnia.
Dosage and Administration
Most allergic conditions are controlled with 25 to 50 mg i.e., (12.5 to 25 ml of syrup) 3 to 4 times a day. Children 6 to 12 years of age : 10 mg i.e.(5 ml of syrup) 3 to 4 times a day.Children 1 to 6 years of age: 5 mg i.e.,
(2.5 ml of syrup) 3 to 4 times a day. In motion sickness: Adults : 25 to 50 mg 3 to 4 times a day. Children (above 9.1 kg): 12.5 to 25 mg 3 to 4 times a day (5mg/ kg/24 hours).
In parkinsonism: Adults: 25 to 50 mg 3 to 4 times a day. Children (above 9.1 kg) : 12.5 to 25 mg 3 to 4 times a day (5mg/ kg/ 24hours).In insomnia: Adults and children over 12 years of old : A dose of 20 to 50 mg is used
as hypnotic in insomnia.
In cough & cold: Adults: 25 mg every 4 hrs. Not to exceed 150 mg in 24 hours. Children (6 to 12 years) : 12.5 mg every 4 hours. Not to exceed 75 mg in 24 hours. Children (2 to 6 years): 6.25 mg every 4 hours.
Contraindication and Precaution
Contraindicated for the premature or newborn infants. Any patients in whom drowsiness is undesirable e.g. drivers, machine operators. Patients with known hypersensitivity to Diphenhydramine or any components of the product. Patients should be cautioned not to operate vehicles or hazardous machinery until their response to the drug has been determined.
Drug Interaction
Antituberculous agent, para-aminosalicylic acid (PAS), alcohol, other CNS depressants (hypnotics, sedatives, tranquilizers, etc), MAO inhibitors.
Side Effect
Side Effects include drowsiness, dizziness, dryness of mouth, blurred vision, nausea and vomiting.
Uses in Pregnancy & Lactation
Should be used in pregnancy only if clearly needed. Use in lactating mother is not recommended.
Preparation
10 mg/5 ml Syrup
Wednesday, May 7, 2014
Carbonyl Iron + Folic Acid + Zinc.
Indication
Treatment and prophylaxis of Iron, Folic Acid and Zinc deficiencyespecially during pregnancy and lactation.
Dosage & Administration
Adult : one capsule daily before food or as directed by the physician.
Contraindication & Precaution
Known hypersensitivity to any of its component or those with Iron overload. Special care with generalized weakness due to vitamins and minerals deficiency.
Dosage & Administration
Adult: One Capsule daily before food or as directed by the physician.
Contraindication & Precaution
It is contraindicated in patients with known hypersensitivity to any of its component
or those with Iron overload. Special care should be taken in patients with Iron overload states, such as haemochromatosis, haemolytic anaemia or red blood cell aplasia. Failure to response to the treatment requires further investigations to exclude other causes of anaemia. In patients with renal failure there may be the risk of Zinc accumulation.
Side Effect
Gastrointestinal irritations such as nausea, anorexia, vomiting, discomfort, constipation and diarrhea may occur. Patients may complain of dark stool. Carbonyl Iron pellets incorporated into the capsules to reduce the possibility of gastrointestinal irritations. Rarely there may be allergic reactions.
Use in Pregnancy & Lactation
Use of any drug during first trimester of pregnancy should be avoided if possible Thus administration of Iron during the first trimester requires definite evidence of Iron deficiency. Prophylaxis of Irondeficiency where inadequate diet calls for supplementary Zinc and Folic acid is justified during the remainder of pregnancy.
Drug Interaction
Carbonyl Iron decreases the absorption of tetracyclineantibiotics, quinolone antibiotics, levodopa, levothyroxine, methyldopa andpenicillamine. Folic Acid interacts with antiepileptics, so plasma concentrations of phenobarbital, phenytoin and primidone Polymaltose Complex, Folic Acid and Zinc
Indication
Prevention and treatment of Iron, Folic Acid and Zinc deficiencies.
Dosage & Administration
One tablet daily. Two tablets may be required a day in severe cases or as recommended by the physician.
Contraindication and Precaution
In patients with a known hypersensitivity to any of the ingredients of this product. Dark coloration of stool may occur which is without clinical significance.
Side Effect
Occasionally gastrointestinal irritation such as sensation of repletion,pressure in the epigastric region, nausea, constipation or diarrhoea may occur.
Drug Interaction
No interaction has been observed.
Use in Pregnancy and Lactation
Use of any drug during the first trimester of pregnancy should be avoided if possible.Thus administration of Iron in the first trimester requires definite evidence of Iron deficiency. Prophylaxis of Iron deficiency where inadequate diet calls for supplementary Zinc and Folic Acid is justified during the remainder of
pregnancy.
Preparation
Each film coated tablet contains Iron (III) Hydroxide Polymaltose Complex 188 mg equivalent to 47 mg elemental Iron, Folic Acid 0.50 mg and Zinc Sulphate Monohydrate 61.80 mg equivalent to 22.50 mg elemental Zinc.
Treatment and prophylaxis of Iron, Folic Acid and Zinc deficiencyespecially during pregnancy and lactation.
Dosage & Administration
Adult : one capsule daily before food or as directed by the physician.
Contraindication & Precaution
Known hypersensitivity to any of its component or those with Iron overload. Special care with generalized weakness due to vitamins and minerals deficiency.
Dosage & Administration
Adult: One Capsule daily before food or as directed by the physician.
Contraindication & Precaution
It is contraindicated in patients with known hypersensitivity to any of its component
or those with Iron overload. Special care should be taken in patients with Iron overload states, such as haemochromatosis, haemolytic anaemia or red blood cell aplasia. Failure to response to the treatment requires further investigations to exclude other causes of anaemia. In patients with renal failure there may be the risk of Zinc accumulation.
Side Effect
Gastrointestinal irritations such as nausea, anorexia, vomiting, discomfort, constipation and diarrhea may occur. Patients may complain of dark stool. Carbonyl Iron pellets incorporated into the capsules to reduce the possibility of gastrointestinal irritations. Rarely there may be allergic reactions.
Use in Pregnancy & Lactation
Use of any drug during first trimester of pregnancy should be avoided if possible Thus administration of Iron during the first trimester requires definite evidence of Iron deficiency. Prophylaxis of Irondeficiency where inadequate diet calls for supplementary Zinc and Folic acid is justified during the remainder of pregnancy.
Drug Interaction
Carbonyl Iron decreases the absorption of tetracyclineantibiotics, quinolone antibiotics, levodopa, levothyroxine, methyldopa andpenicillamine. Folic Acid interacts with antiepileptics, so plasma concentrations of phenobarbital, phenytoin and primidone Polymaltose Complex, Folic Acid and Zinc
Indication
Prevention and treatment of Iron, Folic Acid and Zinc deficiencies.
Dosage & Administration
One tablet daily. Two tablets may be required a day in severe cases or as recommended by the physician.
Contraindication and Precaution
In patients with a known hypersensitivity to any of the ingredients of this product. Dark coloration of stool may occur which is without clinical significance.
Side Effect
Occasionally gastrointestinal irritation such as sensation of repletion,pressure in the epigastric region, nausea, constipation or diarrhoea may occur.
Drug Interaction
No interaction has been observed.
Use in Pregnancy and Lactation
Use of any drug during the first trimester of pregnancy should be avoided if possible.Thus administration of Iron in the first trimester requires definite evidence of Iron deficiency. Prophylaxis of Iron deficiency where inadequate diet calls for supplementary Zinc and Folic Acid is justified during the remainder of
pregnancy.
Preparation
Each film coated tablet contains Iron (III) Hydroxide Polymaltose Complex 188 mg equivalent to 47 mg elemental Iron, Folic Acid 0.50 mg and Zinc Sulphate Monohydrate 61.80 mg equivalent to 22.50 mg elemental Zinc.
Azithromycin
Indication
Bronchitis and pneumonia, sinusitis and pharyngitis/ tonsillitis, otitis media, skin and soft tissue infections, sexually transmitted diseases.
Dosage & Administration
Adults: 500 mg once daily for 3 days. Children: 10 mg/ kg body weight once daily for 3 days.
Contraindication & Precaution
Known hypersensitivity, should not be used in patients with hepatic disease Avoid concomitant administration with terfenadine or astemizole. Precaution should be taken in patients with more severe renal impairment.
Side Effect
Nausea, vomiting, abdominal discomfort (pain/cramps), flatulence, diarrhea, headache, dizziness and skin rashes, reversible elevations in liver transaminases.
Drug Interaction
Antacids, Ergot Derivatives, Digoxin & Cyclosporin, Antihistamines.
Use in Pregnancy and Lactation
The initial treatment of chlamydial cervicitis in pregnancy. In other infections, azithromycin should be used only when clearly needed. Exercise caution when administering to a nursing woman.
Preparation
500 mg Tablet, 250 mg Capsule, 200 mg/5 ml Suspension. patients. Other adverse reactions were reported burning, stinging and irritation upon instillation, contact dermatitis, corneal erosion, dry eye, dysgeusia, nasal congestion, ocular discharge, punctuate keratitis, and sinusitis in less than 1% of patients.
Nitazoxanide.
Indication
Diarrhea caused by Cryptosporidium parvum and Giardia lamblia, Amebiasis and helminth infections.
Dosage & Administration
Age 1 - 3 years: 5 ml (100 mg) twice daily for 3 days, Age 4 - 11 years : 10 ml (200 mg) twice daily for 3 days, Age >12 years : 25 ml or 1 tablet (500 mg) twice daily for 3 days.
Contraindication & Precaution
Known hypersensitivity to Nitazoxanide or any other ingredient in the formulations. Should be administrated with caution to patients with hepatic, renal and biliary disease.
Side Effect
Abdominal pain, diarrhea vomiting and headache have been reported rarely.
Use in Pregnancy & Lactation
Pregnancy category B : This drug should be used during pregnancy only if clearly needed. Nursing mother: Caution should be exercised when Nitazoxanide is administrated to a nursing woman.
Drug Interaction
Caution should be u sed when administering Nitazoxanide concurrently with other highly plasmaprotein bound drugs.
Preparation
500 mg Tablet, 30 ml & 60 ml Suspension (100 mg/5 ml).
Diarrhea caused by Cryptosporidium parvum and Giardia lamblia, Amebiasis and helminth infections.
Dosage & Administration
Age 1 - 3 years: 5 ml (100 mg) twice daily for 3 days, Age 4 - 11 years : 10 ml (200 mg) twice daily for 3 days, Age >12 years : 25 ml or 1 tablet (500 mg) twice daily for 3 days.
Contraindication & Precaution
Known hypersensitivity to Nitazoxanide or any other ingredient in the formulations. Should be administrated with caution to patients with hepatic, renal and biliary disease.
Side Effect
Abdominal pain, diarrhea vomiting and headache have been reported rarely.
Use in Pregnancy & Lactation
Pregnancy category B : This drug should be used during pregnancy only if clearly needed. Nursing mother: Caution should be exercised when Nitazoxanide is administrated to a nursing woman.
Drug Interaction
Caution should be u sed when administering Nitazoxanide concurrently with other highly plasmaprotein bound drugs.
Preparation
500 mg Tablet, 30 ml & 60 ml Suspension (100 mg/5 ml).